In this Mission Matters episode, Adam Torres interviews Doug Drysdale, CEO of Cybin, about the groundbreaking work his company is doing to develop psychedelic-based treatments for mental health conditions. From clinical trials to regulatory challenges, Doug shares his mission to transform suffering into healing through next-generation therapeutics.

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:

https://missionmatters.lpages.co/podcastguest/

Visit our website:

https://missionmatters.com/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices